Item 4.02. Non-Reliance on Previously Issued Financial Statements
or a Related Audit Report or Completed Interim Review.
As previously disclosed in the Company’s March 4,
2021 press release (the “Earnings Release”), the Company, together with its independent auditors, reevaluated the
accounting treatment of the previously disclosed contingent consideration common shares to which the former owners of
AdaptHealth Holdings LLC are entitled (the “Contingent Consideration Common Shares”) in connection with the 2019 business combination with DFB Healthcare Acquisitions Corp, a special purpose acquisition company
(“SPAC”). Due to the fact that the issuance of the Contingent Consideration Common Shares would be accelerated on
a change of control regardless of the transaction value, the Company determined to present the Contingent Consideration Common Shares as
liability-classified, not equity-classified as previously presented. Accordingly, the fair value of the Contingent
Consideration Common Shares is reflected as a liability on the Company’s consolidated balance sheets at December 31,
2020 and 2019, and the change in the fair value of such liability in each period is recognized as a non-cash charge in the
Company’s consolidated statements of operations. The liability does not constitute indebtedness of the Company and will
only be satisfied, if earned, by the Company through the issuance of shares of the Company’s Class A common stock. When
presenting diluted earnings (loss) per share for 2020 and 2019 periods in the Company’s Form 10-K for the year ended
December 31, 2019 (the “2019 Annual Report”) and in the Company’s Form 10-Q filings for the 2020 quarterly
periods, the Contingent Consideration Common Shares were considered for inclusion in the diluted share count in accordance
with U.S. generally accepted accounting principles. The change in fair value in each period is a non-cash charge and has no
impact on the Company’s historical reported revenues, operating income, Adjusted EBITDA (as defined in the Earnings
Release), Adjusted EBITDA less Patient Equipment Capex (as defined in the Earnings Release), or cash flows from operating
activities, investing activities, and financing activities for any period.
On March 3, 2021, after discussion with KPMG LLP, the
Company’s independent registered public accounting firm, the Company’s management and the Audit Committee of the
Company’s board of directors (the “Audit Committee”) concluded that it is appropriate to correct such
errors in its previously issued (x) unaudited condensed consolidated statements of operations for the three months ended
March 31, 2020, and the three-month and year-to-date periods ended June 30, 2020 and September 30, 2020, and (y) unaudited
condensed consolidated balance sheets as of March 31, 2020, June 30, 2020 and September 30, 2020 (the “Relevant
Periods”) by restating such unaudited condensed consolidated financial information because the errors were material to
the unaudited condensed consolidated financial information for each of the Relevant Periods (with the exception of the
unaudited condensed consolidated statements of operations for the three months ended June 30, 2020 for which the impact was
not material). Considering such restatements, such unaudited condensed consolidated financial statements should no longer be
relied upon. The Company’s management and the Audit Committee has concluded that the impact of the error on the
Company’s audited consolidated financial statements as of and for the year ended December 31, 2019 included in the 2019
Annual Report was not material.
The impacts of these corrections to the Relevant Periods are
as follows (in thousands, except per share data):
|
|
March 31, 2020
|
|
|
June 30, 2020
|
|
|
September 30, 2020
|
|
|
|
As Reported
|
|
|
As Restated
|
|
|
As Reported
|
|
|
As Restated
|
|
|
As Reported
|
|
|
As Restated
|
|
Consolidated Balance Sheets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred tax assets
|
|
$
|
33,519
|
|
|
$
|
36,684
|
|
|
$
|
42,304
|
|
|
$
|
45,462
|
|
|
$
|
51,114
|
|
|
$
|
58,557
|
|
Total Assets
|
|
$
|
661,839
|
|
|
$
|
665,004
|
|
|
$
|
739,309
|
|
|
$
|
742,467
|
|
|
$
|
1,548,826
|
|
|
$
|
1,556,269
|
|
Contingent consideration common shares liability - current portion
|
|
$
|
—
|
|
|
$
|
10,293
|
|
|
$
|
—
|
|
|
$
|
10,604
|
|
|
$
|
—
|
|
|
$
|
21,465
|
|
Long-term portion of contingent consideration common shares liability
|
|
$
|
—
|
|
|
$
|
15,390
|
|
|
$
|
—
|
|
|
$
|
15,037
|
|
|
$
|
—
|
|
|
$
|
29,701
|
|
Total Liabilities
|
|
$
|
691,285
|
|
|
$
|
716,968
|
|
|
$
|
746,103
|
|
|
$
|
771,744
|
|
|
$
|
1,109,111
|
|
|
$
|
1,160,277
|
|
Additional paid-in capital
|
|
$
|
21,845
|
|
|
$
|
12,946
|
|
|
$
|
37,614
|
|
|
$
|
28,715
|
|
|
$
|
476,861
|
|
|
$
|
467,962
|
|
Accumulated deficit
|
|
$
|
(27,368
|
)
|
|
$
|
(40,987
|
)
|
|
$
|
(23,335
|
)
|
|
$
|
(36,919
|
)
|
|
$
|
(23,130
|
)
|
|
$
|
(57,954
|
)
|
Total stockholders' equity (deficit) attributable to AdaptHealth Corp.
|
|
$
|
(10,655
|
)
|
|
$
|
(33,173
|
)
|
|
$
|
8,491
|
|
|
$
|
(13,992
|
)
|
|
$
|
448,630
|
|
|
$
|
404,907
|
|
Total stockholders' equity (deficit)
|
|
$
|
(29,446
|
)
|
|
$
|
(51,964
|
)
|
|
$
|
(6,794
|
)
|
|
$
|
(29,277
|
)
|
|
$
|
439,715
|
|
|
$
|
395,992
|
|
|
|
Three Months Ended March 31, 2020
|
|
|
Three Months Ended
June 30, 2020
|
|
|
Six Months Ended
June 30, 2020
|
|
|
|
As Reported
|
|
|
As Restated
|
|
|
As Reported
|
|
|
As Revised
|
|
|
As Reported
|
|
|
As Revised
|
|
Consolidated Statements of Operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in fair value of contingent consideration common shares liability
|
|
$
|
—
|
|
|
$
|
16,367
|
|
|
|
—
|
|
|
|
(42
|
)
|
|
|
—
|
|
|
|
16,325
|
|
Income tax expense (benefit)
|
|
$
|
1,107
|
|
|
$
|
(1,641
|
)
|
|
|
1,819
|
|
|
|
1,826
|
|
|
|
2,926
|
|
|
|
185
|
|
Net income (loss)
|
|
$
|
266
|
|
|
$
|
(13,353
|
)
|
|
|
7,169
|
|
|
|
7,204
|
|
|
|
7,435
|
|
|
|
(6,149
|
)
|
Net income (loss) attributable to AdaptHealth Corp.
|
|
$
|
(158
|
)
|
|
$
|
(13,777
|
)
|
|
|
4,033
|
|
|
|
4,068
|
|
|
|
3,875
|
|
|
|
(9,709
|
)
|
Basic earnings (loss) per share attributable to AdaptHealth Corp.
|
|
$
|
—
|
|
|
$
|
(0.33
|
)
|
|
|
0.09
|
|
|
|
0.09
|
|
|
|
0.09
|
|
|
|
(0.22
|
)
|
Diluted earnings (loss) per share attributable to AdaptHealth Corp.
|
|
$
|
—
|
|
|
$
|
(0.33
|
)
|
|
|
0.08
|
|
|
|
0.08
|
|
|
|
0.08
|
|
|
|
(0.22
|
)
|
|
|
Three Months Ended
September 30, 2020
|
|
|
Nine Months Ended
September 30, 2020
|
|
|
|
As Reported
|
|
|
As Restated
|
|
|
As Reported
|
|
|
As Revised
|
|
Consolidated Statements of Operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in fair value of contingent consideration common shares liability
|
|
$
|
—
|
|
|
$
|
25,525
|
|
|
$
|
—
|
|
|
$
|
41,850
|
|
Income tax expense (benefit)
|
|
$
|
(636
|
)
|
|
$
|
(4,921
|
)
|
|
$
|
2,290
|
|
|
$
|
(4,736
|
)
|
Net income (loss)
|
|
$
|
(3,827
|
)
|
|
$
|
(25,067
|
)
|
|
$
|
3,608
|
|
|
$
|
(31,216
|
)
|
Net income (loss) attributable to AdaptHealth Corp.
|
|
$
|
(2,489
|
)
|
|
$
|
(23,729
|
)
|
|
$
|
1,386
|
|
|
$
|
(33,438
|
)
|
Basic earnings (loss) per share attributable to AdaptHealth Corp.
|
|
$
|
(0.04
|
)
|
|
$
|
(0.41
|
)
|
|
$
|
0.03
|
|
|
$
|
(0.70
|
)
|
Diluted earnings (loss) per share attributable to AdaptHealth Corp.
|
|
$
|
(0.04
|
)
|
|
$
|
(0.41
|
)
|
|
$
|
0.02
|
|
|
$
|
(0.70
|
)
|
The Company intends to include the restated unaudited interim
financial information for the Relevant Periods in the Company’s Form 10-K for the year ended December 31, 2020 (the “2020
Annual Report”), which it expects to file on or before March 16, 2021. The Company will revise its unaudited 2020 interim
consolidated financial information in connection with the filing of its Quarterly Reports on Form 10-Q for the quarters ending
March 31, June 30 and September 30, 2021. The Company will revise its December 31, 2019 consolidated balance sheet in conjunction
with filing the 2020 Annual Report to reflect a $9.3 million total contingent consideration common shares liability and a related
increase in deferred tax assets of $0.4 million, as previously disclosed in the Earnings Release. The Company will also correct
the unaudited pro forma financial information filed on its December 14, 2020 Form 8-K with respect to the acquisition of AeroCare
Holdings, Inc. (the “Pro Formas 8-K”) by filing an amendment to the Pro Formas 8-K.
The Company is in the process of finalizing its evaluation of internal controls over financial reporting and expects to report on any
material weaknesses in the 2020 Annual Report.
The Company’s management and the Audit Committee have
discussed the matters disclosed in this Item 4.02 with the Company’s independent registered public accounting firm, KPMG
LLP.